Monoclonal Antibody Controversy

The Biden administration's recent decision to federalize the distribution of monoclonal antibodies has sparked controversy, particularly as it appears to prioritize equity over need. DeSantis argues that this move is a politically motivated act of retribution against states like Florida and Texas. The discussion highlights the tension between state needs and federal control, raising questions about the implications of equitable distribution in healthcare.